AI Science Tracker
EN

Pre-treatment Tumor Volume Growth Rate and Baseline Volume Measured by an Artificial Intelligence Program Predict Overall Survival in Patients With Pleural Mesothelioma Undergoing Deferred Systemic Th

Affiliation not stated in the reviewed material · 30 Jun 2026 · medicine

Discovery

Pre-treatment Tumor Volume Growth Rate and Baseline Volume Measured by an Artificial Intelligence Program Predict Overall Survival in Patients With Pleural Mesothelioma Undergoing Deferred Systemic Th

Source check: Source checked. Not independent scientific confirmation.

Finding: single-center retrospective cohort of 71 mesothelioma patients with serial pretreatment CT; an AI segmentation program measured tumor volumes/growth rates; Cox/Kaplan-Meier analyses found associations with overall survival. A bounded prognostic association, not causal or external validation. Published in JTO Clinical and Research Reports.

Technology: Primary Methods/Results: single-center retrospective cohort of 71 mesothelioma patients with serial pretreatment CT; an AI segmentation program measured tumor volumes/growth rates; Cox/Kaplan-Meier analyses found associations with overall survival. A bounded prognostic association, not causal or external validation.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
single-center retrospective cohort of 71 mesothelioma patients with serial pretreatment CT; an AI segmentation program measured tumor volumes/growth rates; Cox/Kaplan-Meier analyses found associations with overall survival. A bounded prognostic association, not causal or external validation.
Test and result
single-center retrospective cohort of 71 mesothelioma patients with serial pretreatment CT; an AI segmentation program measured tumor volumes/growth rates; Cox/Kaplan-Meier analyses found associations with overall survival. A bounded prognostic association, not causal or external validation.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study; author affiliation is not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13544273/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.